Adenovirus-mediated tissue factor pathway inhibitor gene transfer induces apoptosis by blocking the phosphorylation of JAK-2/STAT-3 pathway in vascular smooth muscle cells

Cellular Signalling

Volumn 24, Issue 10, 2012, Pages 1909-1917

  Fu, Yu ^a   Zhao, Yong ^a   Liu, Yue ^a   Zhu, Yejing ^a   Chi, Jinyu ^a   Hu, Jing ^b   Zhang, Xiaohui ^a   Yin, Xinhua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; JAK 2 STAT 3; Restenosis; Survivin; Tissue factor pathway inhibitor; Vascular smooth muscle cell

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYCLIN D1; JANUS KINASE 2; PROTEIN BCL 2; STAT3 PROTEIN; SURVIVIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; TFPI GENE; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; APOPTOSIS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; JANUS KINASE 2; LIPOPROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

ADENOVIRIDAE; RATTUS;

EID: 84864004711     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.06.001     Document Type: Article

References (34)

1. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., Leon M.B. Circulation 1999, 100:1872-1878.
2. Williams D.O., Holubkov R., Yeh W., Bourassa M.G., Al-Bassam M., Block P.C., Coady P., Cohen H., Cowley M., Dorros G., Faxon D., Holmes D.R., Jacobs A., Kelsey S.F., King S.B., Myler R., Slater J., Stanek V., Vlachos H.A., Detre K.M. Circulation 2000, 102:2945-2951.
3. Lefkovits J., Topol E.J. Progress in Cardiovascular Diseases 1997, 40:141-158.
4. Marks A.R. Transplantation Proceedings 2000, 35(3 Suppl.):231S-233S.
5. Caplice N.M., Mueske C.S., Kleppe L.S., Peterson T.E., Broze G.J., Simari R.D. Circulation Research 1998, 83:1264-1270.
6. Kopp C.W., Hölzenbein T., Steiner S., Marculescu R., Bergmeister H., Seidinger D., Mosberger I., Kaun C., Cejna M., Horvat R., Wojta J., Maurer G., Binder B.R., Breuss J.M., Ecker R.C., de Martin R., Minar E. Blood 2004, 103:1653-1661.
7. Singh R., Pan S., Mueske C.S., Witt T., Kleppe L.S., Peterson T.E., Slobodova A., Chang J.Y., Caplice N.M., Simari R.D. Circulation Research 2001, 89:71-76.
8. Zoldhelyi P., Chen Z.Q., Shelat H.S., McNatt J.M., Willerson J.T. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:4078-4083.
9. Yin X., Yutani C., Ikeda Y., Enjyoji K., Ishibashi-Ueda H., Yasuda S., Tsukamoto Y., Nonogi H., Kaneda Y., Kato H. Cardiovascular Research 2002, 56:454-463.
10. Yin X., Fu Y., Yutani C., Ikeda Y., Enjyoji K., Kato H. International Journal of Cardiology 2009, 135:245-248.
11. Fu Y., Zhang Z., Zhang G., Liu Y., Cao Y., Yu J., Hu J., Yin X. Apoptosis 2008, 13:634-640.
12. Darnell J.E. Science 1997, 277:1630-1635.
13. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Cell 1999, 98:295-303.
14. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., Kim J.D. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:4227-4232.
15. Ho Y.S., Lee H.M., Mou T.C., Wang Y.J., Lin J.K. Molecular Carcinogenesis 1997, 19:101-113.
16. Cooney R.N. Shock 2002, 17:83-90.
17. Lin Y.F., Zhang N., Guo H.S., Kong D.S., Jiang T., Liang W., Zhao Z.H., Tang Q.Q., Ma D. Apoptosis 2007, 12:2163-2173.
18. Amirkhosravi A., Meyer T., Amaya M., Davila M., Mousa S.A., Robson T., Francis J.L. Seminars in Thrombosis and Hemostasis 2007, 33:643-652.
19. Hamuro T., Kamikubo Y., Nakahara Y., Miyamoto S., Funatsu A. FEBS Letters 1998, 421:197-202.
20. Tasiou A., Konduri S.D., Yanamandra N., Dinh D.H., Olivero W.C., Gujrati M., Obeyesekere M., Rao J.S. International Journal of Oncology 2001, 19:591-597.
21. Wu Y.Y., Bradshaw R.A. Journal of Biological Chemistry 2000, 275:2147-2156.
22. Sahu R.P., Srivastava S.K. Journal of the National Cancer Institute 2009, 101:176-193.
23. Lassmann S., Schuster I., Walch A., Göbel H., Jütting U., Makowiec F., Hopt U., Werner M. Journal of Clinical Pathology 2007, 60:173-179.
24. Shibata R., Kai H., Seki Y., Kato S., Wada Y., Hanakawa Y., Hashimoto K., Yoshimura A., Imaizumi T. Human Gene Therapy 2003, 14:601-610.
25. Dronadula N., Liu Z., Wang C., Cao H., Rao G.N. Journal of Biological Chemistry 2005, 280:3112-3120.
26. Madamanchi N.R., Li S., Patterson C., Runge M.S. Journal of Biological Chemistry 2001, 276:18915-18924.
27. Hackeng T.M., Rosing J. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:2015-2020.
28. Zhang C., Li B., Gaikwad A.S., Haridas V., Xu Z., Gutterman J.U., Duvic M. Journal of Investigative Dermatology 2008, 28:2728-2735.
29. Tammali R., Saxena A., Srivastava S.K., Ramana K.V. Endocrinology 2010, 151:2140-2150.
30. Masamha C.P., Benbrook D.M. Cancer Research 2009, 69:6565-6572.
31. Altieri D.C. Trends in Molecular Medicine 2001, 7:542-547.
32. Simosa H.F., Wang G., Sui X., Peterson T., Narra V., Altieri D.C., Conte M.S. Journal of Vascular Surgery 2005, 41:682-690.
33. Marsboom G., Archer S. Circulation Research 2008, 103:1047-1049.
34. Suzuki A., Ito T., Kawano H., Hayashida M., Hayasaki Y., Tsutomi Y., Akahane K., Nakano T., Miura M., Shiraki K. Oncogene 2000, 19:1346-1353.